Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: Differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum

Photochemistry and Photobiology

Volumn 72, Issue 5, 2000, Pages 681-689

  Van Den Akker, Johanna T H M ^a,b   Iani, Vladimir ^a   Star, Willem M ^c   Sterenborg, Henricus J C M ^c   Moan, Johan ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; FEMALE; FLUORESCENCE; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIZATION; STRATUM CORNEUM;

AMINOLEVULINIC ACID; ANIMALS; FEMALE; FLUORESCENCE; MICE; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN;

ANIMALIA; MUS MUSCULUS;

EID: 0034335291     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2000)072<0681:TAOAAH>2.0.CO;2     Document Type: Article

References (39)

1. Kennedy, J. C., R. H. Pottier and D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol. 6, 143-148.
2. Peng, Q., K. Berg, J. Moan, M. Kongshaug and J. M. Nesland (1997) 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65, 235-251.
3. Kennedy, J. C., S. L. Marcus and R. H. Pottier (1996) Photodynamic therapy and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid: mechanisms and clinical results. J. Clin. Laser Med. Surg. 14, 289-304.
4. Peng, Q., T. Warloe, J. Moan, H. Heyerdahl, H. B. Steen, J. M. Nesland and K.-E. Giercksky (1995) Distribution of 5-amino-levulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinoma. Photochem. Photobiol. 62, 906-913.
5. Cairnduff, F., M. Springer, E. J. Hudson, D. V. Ash and S. B. Brown (1994) Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69, 605-608.
6. Szeimies, R.-M., T. Sassy and M. Landthaler (1994) Penetration potency of topical applied L-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem. Photobiol. 59, 73-76.
7. Kloek, J. and G. M. J. Beijersbergen van Henegouwen (1996) Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. 64, 994-1000.
8. Kloek, J., W. Akkermans and G. M. J. Beijersbergen van Henegouwen (1998) Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 67, 150-154.
9. Gaullier, J.-M., K. Berg, Q. Peng, H. Anholt, P. K. Selbo, L.-W. Ma and J. Moan (1997) Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 57, 1481-1486.
10. Washbrook, R. and P. A. Riley (1997) Comparison of 8-aminolaevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells. Br. J. Cancer 75, 1417-1420.
11. Casas, A., A. M. del C. Battle, A. R. Butler, D. Robertson, E. H. Brown, A. MacRobert and P. A. Riley (1999) Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br. J. Cancer 80, 1525-1532.
12. Peng, Q., J. Moan, T. Warloe, V. Iani, H. B. Steen, A. Bjorseth and J. M. Nesland (1996) Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J. Photochem. Photobiol. B: Biol. 34, 95-96.
13. Fritsch, C., B. Homey, W. Stahl, P. Lehmann, T. Ruzicka and H. Sies (1998) Preferential relative porphyrin enrichment in solar keratoses upon topical application of δ-aminolevulinic acid methylester. Photochem. Photobiol. 68, 218-221.
14. Marti, A., N. Lange, H. van den Bergh, D. Sedmera, P. Jichlinski and P. Kucera (1999) Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J. Urol. 162, 546-552.
15. Lange, N., P. Jichlinski, M. Zellweger, M. Forrer, A. Marti, L. Guillou, P. Kucera, G. A. Wagnières and H. van den Bergh (1999) Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br. J. Cancer 80, 185-193.
16. van den Akker, J. T. H. M., H. S. de Bruijn, G. M. J. Beijersbergen van Henegouwen, W. M. Star and H. J. C. M. Sterenborg (2000) Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. Photochem. Photobiol. 72, 399-406.
17. Williams, A. C. and B. W. Barry (1992) Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9, 305-353.
18. Suhonen, T. M., J. A. Bouwstra and A. Urtti (1999) Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Controlled Release 59, 149-161.
19. Landmann, L. (1988) The epidermal permeability barrier. Anat. Embryol. 178, 1-13.
20. Menton, D. N. and A. Z. Eisen (1971) Structure and organisation of mammalian stratum corneum. J. Ultrastruct. Res. 35, 247-264.
21. 1 through hairless mouse skin: combined use of carboxymethyl-ethyl-b-cyclodextrin and penetration enhancers. J. Pharm. Pharmacol. 44, 119-121.
22. Yano, T., N. Higo, K. Fukuda, M. Tsuji, K. Noda and M. Otagiri (1993) Further evaluation of a new penetration enhancer, HPE-101. J. Pharm. Pharmacol. 45, 775-778.
23. Hadgraft, J., K. A. Waiters and R. H. Guy (1992) Epidermal lipids and topical drug delivery. Semin. Dermatol. 11, 139-144.
24. Yano, T., K. Furukawa, M. Tsuji, K. Noda and M. Otagiri (1992) Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101). J. Pharmacobiodyn. 15, 527-533.
25. Wiechers, J. W. and R. A. de Zeeuw (1990) Transdermal drug delivery: efficacy and potential applications of the penetration enhancer azone. Drug Des. Del. 6, 87-100.
26. Goff, B. A., R. Bachor, N. Kollias and T. Hasan (1992) Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J. Photochem. Photobiol. B: Biol. 15, 239-251.
27. Cheong, W.-F. (1995) Summary of optical properties. In Optical-thermal Response of Laser-irradiated Tissues, Appendix to Chap. 8 (Edited by A. J. Welch and M. J. C. van Gemert), pp. 275-303. Plenum Press, New York.
28. van der Veen, N., H. S. de Bruijn, R. J. W. Berg and W. M. Star (1996) Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice. Br. J. Cancer 73, 925-930.
29. D'Hallewin, M.-A., H. Vanherzeele and L. Baert (1998) Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid. Am. J. Clin. Oncol. 21, 223-225.
30. Jichlinski, P., M. Forrer, J. Mizeret, T. Glanzmann, D. Braichotte, G. A. Wagnières, G. Zimmer, L. Guillou, F. Schmidlin, P. Graber, H. van den Bergh and H.-J. Leisinger (1997) Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg. Med. 20, 402-408.
31. Hicks, R. M., B. Ketterer and R. C. Warren (1974) The ultra-structure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Philos. Trans. R. Soc. London, Ser. B 268, 23-38.
32. Negrete, H. O., J. P. Lavelle, J. Berg, S. A. Lewis and M. L. Zeidel (1996) Permeability properties of the intact mammalian bladder epithelium. Am. J. Physiol. 271, F886-F894.
33. Fickweiler, E. (1991) Biopharmacy of urologics. Krankenhauspharmazie 10, 424-427.
34. Zeidel, M. L. (1996) Low permeabilities of apical membranes of barrier epithelia: what makes watertight membranes watertight? Am. J. Physiol. 271, F243-F245.
35. Realdon, N., E. Ragazzi, M. dal Zotto and E. Ragazzi (1995) Influence of ointment formulation on skin erythema induced by nicotinate esters. Pharmazie 9, 603-606.
36. Tsai, J.-C., S.-A. Chuang, M.-Y. Hsu and H.-M. Sheu (1999) Distribution of salicylic acid in human stratum corneum following topical application in vivo: a comparison of six different formulations. Int. J. Pharm. 188, 145-153.
37. Murakami, T., M. Yoshioka, I. Okamoto, R. Yumoto, Y. Higashi, K. Okahara and N. Yata (1998) Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. J. Pharm. Pharmacol. 50, 55-61.
38. Schwarb, F. P., B. Gabard, T. Rufli and C. Surber (1999) Percutaneous absorption of salicylic acid in man after topical administration of three different formulations. Dermatology 198, 44-51.
39. Hennings, H. and K. Elgjo (1970) Epidermal regeneration after cellophane tape stripping of hairless mouse skin. Cell Tissue Kinet. 3, 243-252.